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LETTERS TO THE EDITORAIMP1/p43 Mutation and PMLDTo the Editor: In the December 2010 issue of the American
Journal of Human Genetics, Feinstein et al. reported that
AIMP1/p43 (MIM 603605) homozygous mutation causes
Pelizaeus-Merzbacher-like disease (PMLD [MIM 608804]).1
The term PMLD indicates the autosomal-recessive variant
of Pelizaeus-Merzbacher disease (PMD [MIM 312080])
that is the X-linked prototype of hypomyelinating disor-
ders. The clinical phenotype of PMLD is similar to the
characteristic clinical picture of PMD and is characterized
by nystagmus, impaired motor development, spasticity,
and ataxia.2,3 Seizures are exceedingly unusual. Mild
peripheral neuropathy may occur in some patients.2 The
course tends to be slowly progressive. PMLD is caused by
mutations in GJC2/GJA12 (MIM 608803).2 Brain magnetic
resonance imaging (MRI) studies show diffuse cerebral
hypomyelination similar to the typical MRI pattern of
PMD. The presence of high T2 signal intensity of the pons
has been reported as suggestive of PMLD.4 The clinical
and neuroradiological features of the patients reported by
Feinstein et al.1 seem consistent with a cortical disease
rather than a primary white matter disorder. Severe failure
to thrive with a concordant reduced head circumference,
a rapid neurological deterioration progressing over the first
months of life, and abnormal epileptiform EEG pattern
suggest a cortical disease more than PMLD. On brain MRI
of young children with true hypomyelination, brain
atrophy is mild or absent, whereas early-onset generalized
atrophy, as shown in Figures 2D–2F of the paper, points to
a primary cortical degeneration. Furthermore, the reduced
peak of N-acetyl aspartate found on MR spectroscopy indi-
cates neuronal degeneration, whereas this peak is consid-
ered tobenormalorhigh inhypomyelination.5 Inaddition,
the MRI criterion for a diagnosis of hypomyelination is an
unchanged pattern of deficientmyelination on two succes-
siveMRI scans at least 6months apart.6 Thus,hypomyelina-
tion cannot be diagnosed on the basis of the single MR
examof the 14-month-old girl (Figures 2D–2F of the paper),
despite a similar MRI at later ages in other members of the
family that might be indicative of hypomyelination.
Finally, the major role of AIMP1 in neurons1 further
supports the hypothesis that these patients may suffer
from an early-onset neurodegenerative disorder causing
impaired myelin formation due to neuronal dysfunction,
and not from a primary defect in myelin formation/metab-
olism, as in PMLD.
Because hypomyelinating disorders still represent the
single largest category among undiagnosed leukoencepha-
lopathies,4 the phenotype of possible novel genetic
diseases should be correctly defined to avoid unnecessary
molecular screening in PMLD patients.The AmeriAs final remark, in Figure 2 of the paper,1 panel B is not
a FLAIR sequence and panel D is not a T1-weighted image
(it is likely that these two images have been incorrectly
labeled).
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